| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 9.91e-06 | 37 | 73 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.32e-05 | 2 | 73 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.32e-05 | 2 | 73 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 3.95e-05 | 3 | 73 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.31e-04 | 5 | 73 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.91e-04 | 229 | 73 | 6 | GO:0140993 | |
| GeneOntologyMolecularFunction | NAD+ nucleosidase activity | 8.50e-04 | 12 | 73 | 2 | GO:0003953 | |
| GeneOntologyMolecularFunction | dynactin binding | 8.50e-04 | 12 | 73 | 2 | GO:0034452 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.34e-03 | 15 | 73 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 1.53e-03 | 16 | 73 | 2 | GO:0061809 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.94e-03 | 18 | 73 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.98e-03 | 68 | 73 | 3 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.07e-03 | 69 | 73 | 3 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 2.24e-03 | 71 | 73 | 3 | GO:0042054 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 2.65e-03 | 21 | 73 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | p53 binding | 2.82e-03 | 77 | 73 | 3 | GO:0002039 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 3.28e-03 | 167 | 73 | 4 | GO:0031490 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 3.61e-03 | 84 | 73 | 3 | GO:0003684 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CDKL5 GLI2 SYNE1 PPP1R9A PAFAH1B1 SARM1 ZSWIM6 PTEN ARHGEF25 EP300 PLXNA1 UNC13A NOTCH3 WDR47 | 4.95e-07 | 802 | 71 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CDKL5 GLI2 SYNE1 PPP1R9A PAFAH1B1 SARM1 ZSWIM6 PTEN ARHGEF25 EP300 PLXNA1 UNC13A NOTCH3 WDR47 | 6.36e-07 | 819 | 71 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CDKL5 GLI2 SYNE1 PPP1R9A PAFAH1B1 SARM1 ZSWIM6 PTEN ARHGEF25 EP300 PLXNA1 UNC13A NOTCH3 WDR47 | 7.04e-07 | 826 | 71 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CDKL5 GLI2 SYNE1 PPP1R9A PAFAH1B1 SARM1 PTEN ARHGEF25 EP300 PLXNA1 NOTCH3 WDR47 | 8.51e-06 | 748 | 71 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | motile cilium assembly | 1.31e-05 | 88 | 71 | 5 | GO:0044458 | |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 1.44e-05 | 43 | 71 | 4 | GO:0021955 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 1.55e-05 | 91 | 71 | 5 | GO:0060998 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 2.31e-05 | 248 | 71 | 7 | GO:0120032 | |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 2.33e-05 | 99 | 71 | 5 | GO:0021954 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | 2.49e-05 | 251 | 71 | 7 | GO:0060491 | |
| GeneOntologyBiologicalProcess | neuron projection development | CDKL5 GLI2 SYNE1 PPP1R9A PAFAH1B1 SARM1 ZSWIM6 PTEN ARHGEF25 CREBBP EP300 PLXNA1 UNC13A NOTCH3 WDR47 | 2.55e-05 | 1285 | 71 | 15 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | CDKL5 SYNE1 PPP1R9A PAFAH1B1 SYNE2 SARM1 DZIP1 PLD1 PTEN EP300 PLXNA1 HTT | 2.89e-05 | 846 | 71 | 12 | GO:0120035 |
| GeneOntologyBiologicalProcess | neuron development | CDKL5 GLI2 SYNE1 PPP1R9A PAFAH1B1 SARM1 ZSWIM6 PTEN ARHGEF25 CREBBP EP300 PLXNA1 UNC13A NOTCH3 HTT WDR47 | 2.91e-05 | 1463 | 71 | 16 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | CDKL5 SYNE1 PPP1R9A PAFAH1B1 SYNE2 SARM1 DZIP1 PLD1 PTEN EP300 PLXNA1 HTT | 3.51e-05 | 863 | 71 | 12 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 3.55e-05 | 108 | 71 | 5 | GO:1902017 | |
| GeneOntologyBiologicalProcess | sperm flagellum assembly | 4.14e-05 | 56 | 71 | 4 | GO:0120316 | |
| GeneOntologyBiologicalProcess | forebrain development | 4.44e-05 | 489 | 71 | 9 | GO:0030900 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CDKL5 GLI2 SYNE1 PPP1R9A PAFAH1B1 SARM1 ZSWIM6 PTEN ARHGEF25 EP300 PLXNA1 UNC13A NOTCH3 WDR47 | 4.75e-05 | 1194 | 71 | 14 | GO:0000902 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 6.19e-05 | 198 | 71 | 6 | GO:0048813 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 6.98e-05 | 4 | 71 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 7.91e-05 | 207 | 71 | 6 | GO:1990138 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | CFAP47 DNHD1 CDKL5 SYNE1 PPP1R9A SYNE2 DZIP1 PLD1 HTT ZMYND12 | 9.45e-05 | 670 | 71 | 10 | GO:0120031 |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 9.96e-05 | 70 | 71 | 4 | GO:0060999 | |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 1.03e-04 | 217 | 71 | 6 | GO:0021953 | |
| GeneOntologyBiologicalProcess | cell projection assembly | CFAP47 DNHD1 CDKL5 SYNE1 PPP1R9A SYNE2 DZIP1 PLD1 HTT ZMYND12 | 1.13e-04 | 685 | 71 | 10 | GO:0030031 |
| GeneOntologyBiologicalProcess | dendritic spine development | 1.26e-04 | 141 | 71 | 5 | GO:0060996 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.36e-04 | 566 | 71 | 9 | GO:0007409 | |
| GeneOntologyBiologicalProcess | cilium assembly | 1.41e-04 | 444 | 71 | 8 | GO:0060271 | |
| GeneOntologyBiologicalProcess | cerebral cortex radial glia-guided migration | 1.48e-04 | 30 | 71 | 3 | GO:0021801 | |
| GeneOntologyBiologicalProcess | telencephalon glial cell migration | 1.48e-04 | 30 | 71 | 3 | GO:0022030 | |
| GeneOntologyBiologicalProcess | dendrite development | 1.53e-04 | 335 | 71 | 7 | GO:0016358 | |
| GeneOntologyBiologicalProcess | central nervous system projection neuron axonogenesis | 1.80e-04 | 32 | 71 | 3 | GO:0021952 | |
| GeneOntologyBiologicalProcess | nuclear migration | 2.17e-04 | 34 | 71 | 3 | GO:0007097 | |
| GeneOntologyBiologicalProcess | cilium organization | 2.26e-04 | 476 | 71 | 8 | GO:0044782 | |
| GeneOntologyBiologicalProcess | centrosome localization | 2.36e-04 | 35 | 71 | 3 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 2.57e-04 | 36 | 71 | 3 | GO:0061842 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | 2.86e-04 | 493 | 71 | 8 | GO:0007018 | |
| GeneOntologyBiologicalProcess | head development | GLI2 PAFAH1B1 SYNE2 ZSWIM6 PTEN CREBBP EP300 PLXNA1 NOTCH3 HTT WDR47 | 2.86e-04 | 919 | 71 | 11 | GO:0060322 |
| GeneOntologyBiologicalProcess | learning or memory | 2.94e-04 | 373 | 71 | 7 | GO:0007611 | |
| GeneOntologyBiologicalProcess | axon development | 3.45e-04 | 642 | 71 | 9 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cerebral cortex radially oriented cell migration | 4.08e-04 | 42 | 71 | 3 | GO:0021799 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 4.41e-04 | 103 | 71 | 4 | GO:0048814 | |
| GeneOntologyBiologicalProcess | nucleus localization | 4.68e-04 | 44 | 71 | 3 | GO:0051647 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 5.25e-04 | 192 | 71 | 5 | GO:0050770 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 5.74e-04 | 299 | 71 | 6 | GO:0060560 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 5.94e-04 | 301 | 71 | 6 | GO:0048588 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 6.07e-04 | 421 | 71 | 7 | GO:0048638 | |
| GeneOntologyBiologicalProcess | cognition | 6.24e-04 | 423 | 71 | 7 | GO:0050890 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase I | 6.30e-04 | 11 | 71 | 2 | GO:0016479 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 6.47e-04 | 114 | 71 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 7.87e-04 | 210 | 71 | 5 | GO:0060294 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 7.88e-04 | 720 | 71 | 9 | GO:0000226 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 8.75e-04 | 215 | 71 | 5 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 8.75e-04 | 215 | 71 | 5 | GO:0001539 | |
| GeneOntologyBiologicalProcess | positive regulation of axon extension | 9.02e-04 | 55 | 71 | 3 | GO:0045773 | |
| GeneOntologyBiologicalProcess | behavior | RAPGEF3 PAFAH1B1 NTS PTEN CREBBP EP300 MCOLN3 CRHR2 HTT WDR47 | 9.10e-04 | 891 | 71 | 10 | GO:0007610 |
| GeneOntologyBiologicalProcess | defense response to other organism | TTLL12 ACOD1 NTS SARM1 PLD1 PTEN DDX21 TTC4 USP27X IL1RL2 TF CREBBP EP300 | 9.24e-04 | 1407 | 71 | 13 | GO:0098542 |
| GeneOntologyBiologicalProcess | microtubule-based process | CFAP47 DNHD1 PAFAH1B1 SYNE2 CHD3 DZIP1 PTEN DNAH9 HTT ZMYND12 WDR47 | 9.30e-04 | 1058 | 71 | 11 | GO:0007017 |
| GeneOntologyBiologicalProcess | protein destabilization | 9.51e-04 | 56 | 71 | 3 | GO:0031648 | |
| GeneOntologyBiologicalProcess | cerebral cortex cell migration | 9.51e-04 | 56 | 71 | 3 | GO:0021795 | |
| GeneOntologyBiologicalProcess | telencephalon development | 9.89e-04 | 332 | 71 | 6 | GO:0021537 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue growth | 1.04e-03 | 14 | 71 | 2 | GO:0048630 | |
| GeneOntologyBiologicalProcess | regulation of cell size | 1.07e-03 | 225 | 71 | 5 | GO:0008361 | |
| GeneOntologyBiologicalProcess | developmental growth | CDKL5 JARID2 GLI2 TLL2 PAFAH1B1 PTEN EP300 PLXNA1 UNC13A CRHR2 | 1.08e-03 | 911 | 71 | 10 | GO:0048589 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 1.18e-03 | 612 | 71 | 8 | GO:0010975 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | CDKL5 RAPGEF3 SYNE1 PPP1R9A PAFAH1B1 SARM1 PTEN EP300 PLXNA1 UNC13A CRHR2 | 1.18e-03 | 1090 | 71 | 11 | GO:0022603 |
| GeneOntologyBiologicalProcess | negative regulation of excitatory postsynaptic potential | 1.19e-03 | 15 | 71 | 2 | GO:0090394 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 1.36e-03 | 16 | 71 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 1.36e-03 | 16 | 71 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine morphogenesis | 1.40e-03 | 64 | 71 | 3 | GO:0061001 | |
| GeneOntologyBiologicalProcess | regulation of collagen biosynthetic process | 1.47e-03 | 65 | 71 | 3 | GO:0032965 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.54e-03 | 494 | 71 | 7 | GO:0031346 | |
| GeneOntologyBiologicalProcess | long-term synaptic potentiation | 1.54e-03 | 144 | 71 | 4 | GO:0060291 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CDKL5 DRP2 RAPGEF3 SYNE1 PPP1R9A PAFAH1B1 NTS SARM1 PTEN TF DDC CRHR2 HTT WDR47 | 1.21e-04 | 1228 | 76 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | distal axon | 1.80e-04 | 435 | 76 | 8 | GO:0150034 | |
| GeneOntologyCellularComponent | motile cilium | 3.07e-04 | 355 | 76 | 7 | GO:0031514 | |
| GeneOntologyCellularComponent | cytoplasmic region | 3.34e-04 | 360 | 76 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | axon | CDKL5 RAPGEF3 PPP1R9A PAFAH1B1 NTS SARM1 DDC UNC13A CRHR2 HTT WDR47 | 3.60e-04 | 891 | 76 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | actin-based cell projection | 5.26e-04 | 278 | 76 | 6 | GO:0098858 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 7.02e-04 | 11 | 76 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 7.02e-04 | 11 | 76 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 7.02e-04 | 11 | 76 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 7.02e-04 | 11 | 76 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | neuromuscular junction | 7.45e-04 | 112 | 76 | 4 | GO:0031594 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.04e-03 | 317 | 76 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | filopodium | 1.06e-03 | 123 | 76 | 4 | GO:0030175 | |
| GeneOntologyCellularComponent | dendrite | 1.06e-03 | 858 | 76 | 10 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.08e-03 | 860 | 76 | 10 | GO:0097447 | |
| GeneOntologyCellularComponent | PML body | 1.12e-03 | 125 | 76 | 4 | GO:0016605 | |
| GeneOntologyCellularComponent | late endosome | 1.67e-03 | 348 | 76 | 6 | GO:0005770 | |
| GeneOntologyCellularComponent | growth cone | 1.99e-03 | 245 | 76 | 5 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.29e-03 | 253 | 76 | 5 | GO:0030427 | |
| GeneOntologyCellularComponent | filopodium membrane | 2.62e-03 | 21 | 76 | 2 | GO:0031527 | |
| GeneOntologyCellularComponent | neuronal cell body | 3.22e-03 | 835 | 76 | 9 | GO:0043025 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.71e-03 | 25 | 76 | 2 | GO:0005858 | |
| HumanPheno | Dilation of Virchow-Robin spaces | 1.56e-06 | 18 | 26 | 4 | HP:0012520 | |
| HumanPheno | Abnormal subclavian artery morphology | 1.90e-05 | 11 | 26 | 3 | HP:0031251 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 1.97e-05 | 33 | 26 | 4 | HP:0011587 | |
| HumanPheno | Plantar crease between first and second toes | 2.51e-05 | 2 | 26 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.51e-05 | 2 | 26 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 2.51e-05 | 2 | 26 | 2 | HP:0001042 | |
| HumanPheno | Prominent forehead | 2.98e-05 | 261 | 26 | 8 | HP:0011220 | |
| HumanPheno | Keloids | 3.26e-05 | 13 | 26 | 3 | HP:0010562 | |
| HumanPheno | Parietal foramina | 4.14e-05 | 14 | 26 | 3 | HP:0002697 | |
| HumanPheno | Perseverative thought | 6.09e-05 | 377 | 26 | 9 | HP:0030223 | |
| HumanPheno | Disordered formal thought process | 7.34e-05 | 386 | 26 | 9 | HP:0025769 | |
| HumanPheno | Laryngeal cartilage malformation | 7.49e-05 | 3 | 26 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 7.49e-05 | 3 | 26 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 7.49e-05 | 3 | 26 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 7.49e-05 | 3 | 26 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 7.49e-05 | 3 | 26 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 7.49e-05 | 3 | 26 | 2 | HP:0005895 | |
| HumanPheno | Advanced eruption of teeth | 7.53e-05 | 46 | 26 | 4 | HP:0006288 | |
| HumanPheno | Tongue thrusting | 7.66e-05 | 17 | 26 | 3 | HP:0100703 | |
| HumanPheno | Broad phalanx of the toes | 8.20e-05 | 47 | 26 | 4 | HP:0010174 | |
| HumanPheno | Skin appendage neoplasm | 9.16e-05 | 18 | 26 | 3 | HP:0012842 | |
| HumanPheno | Abnormal thought pattern | 1.05e-04 | 404 | 26 | 9 | HP:5200269 | |
| HumanPheno | Ptosis | JARID2 GLI2 SYNE1 SYNE2 ZSWIM6 PTEN CREBBP DDC EP300 PLXNA1 NOTCH3 CAPN15 | 1.32e-04 | 754 | 26 | 12 | HP:0000508 |
| HumanPheno | Trichiasis | 1.49e-04 | 4 | 26 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.49e-04 | 4 | 26 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 1.49e-04 | 4 | 26 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.49e-04 | 4 | 26 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 1.49e-04 | 4 | 26 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.49e-04 | 4 | 26 | 2 | HP:0031207 | |
| HumanPheno | Benign neoplasm of the central nervous system | 1.58e-04 | 105 | 26 | 5 | HP:0100835 | |
| HumanPheno | Abnormal spermatogenesis | CFAP47 DNHD1 GLI2 SYNE1 PAFAH1B1 CHD3 CHD6 ZSWIM6 DZIP1 PLD1 PTEN DNAH9 CREBBP EP300 NOTCH3 | 1.68e-04 | 1190 | 26 | 15 | HP:0008669 |
| HumanPheno | Simple ear | 2.23e-04 | 24 | 26 | 3 | HP:0020206 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 2.48e-04 | 5 | 26 | 2 | HP:0009715 | |
| HumanPheno | Rib exostoses | 2.48e-04 | 5 | 26 | 2 | HP:0000896 | |
| HumanPheno | Supernumerary cusp | 2.48e-04 | 5 | 26 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 2.48e-04 | 5 | 26 | 2 | HP:0030421 | |
| HumanPheno | Steroetypic movements of face and head | 2.59e-04 | 63 | 26 | 4 | HP:5200017 | |
| HumanPheno | Abnormal male internal genitalia morphology | CFAP47 DNHD1 GLI2 SYNE1 PAFAH1B1 CHD3 CHD6 ZSWIM6 DZIP1 PLD1 PTEN DNAH9 CREBBP EP300 NOTCH3 | 2.82e-04 | 1243 | 26 | 15 | HP:0000022 |
| HumanPheno | Perimembranous ventricular septal defect | 2.84e-04 | 26 | 26 | 3 | HP:0011682 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 3.38e-04 | 368 | 26 | 8 | HP:0031432 | |
| HumanPheno | Absent sperm flagella | 3.55e-04 | 28 | 26 | 3 | HP:0032558 | |
| HumanPheno | Functional abnormality of male internal genitalia | CFAP47 DNHD1 GLI2 SYNE1 PAFAH1B1 CHD3 CHD6 ZSWIM6 DZIP1 PLD1 PTEN DNAH9 CREBBP EP300 NOTCH3 | 3.61e-04 | 1269 | 26 | 15 | HP:0000025 |
| HumanPheno | Abnormally slow thought process | 3.71e-04 | 6 | 26 | 2 | HP:0031843 | |
| HumanPheno | Abnormal muscle fiber emerin | 3.71e-04 | 6 | 26 | 2 | HP:0030116 | |
| HumanPheno | Absent muscle fiber emerin | 3.71e-04 | 6 | 26 | 2 | HP:0030117 | |
| HumanPheno | Large foramen magnum | 3.71e-04 | 6 | 26 | 2 | HP:0002700 | |
| HumanPheno | Motor stereotypy | 3.74e-04 | 280 | 26 | 7 | HP:0000733 | |
| HumanPheno | Abnormality of the male genitalia | CFAP47 DNHD1 CDKL5 GLI2 SYNE1 PAFAH1B1 CHD3 CHD6 ZSWIM6 DZIP1 PLD1 PTEN DNAH9 CREBBP EP300 NOTCH3 | 3.86e-04 | 1437 | 26 | 16 | HP:0010461 |
| HumanPheno | Abnormal parietal bone morphology | 3.95e-04 | 29 | 26 | 3 | HP:0002696 | |
| HumanPheno | Preaxial foot polydactyly | 4.37e-04 | 30 | 26 | 3 | HP:0001841 | |
| HumanPheno | Deep philtrum | 5.07e-04 | 75 | 26 | 4 | HP:0002002 | |
| HumanPheno | Decreased cervical spine flexion due to contractures of posterior cervical muscles | 5.18e-04 | 7 | 26 | 2 | HP:0004631 | |
| HumanPheno | Deviated nasal septum | 5.18e-04 | 7 | 26 | 2 | HP:0004411 | |
| HumanPheno | Abnormal male reproductive system physiology | CFAP47 DNHD1 GLI2 SYNE1 PAFAH1B1 CHD3 CHD6 ZSWIM6 DZIP1 PLD1 PTEN DNAH9 CREBBP EP300 NOTCH3 | 5.43e-04 | 1314 | 26 | 15 | HP:0012874 |
| HumanPheno | Syringomyelia | 5.82e-04 | 33 | 26 | 3 | HP:0003396 | |
| HumanPheno | Movement abnormality of the tongue | 5.82e-04 | 33 | 26 | 3 | HP:0000182 | |
| HumanPheno | Short sperm flagella | 5.82e-04 | 33 | 26 | 3 | HP:0032559 | |
| HumanPheno | Abnormal internal genitalia | CFAP47 DNHD1 GLI2 SYNE1 PAFAH1B1 CHD3 CHD6 ZSWIM6 DZIP1 PLD1 PTEN DNAH9 CREBBP EP300 NOTCH3 CAPN15 | 6.46e-04 | 1498 | 26 | 16 | HP:0000812 |
| HumanPheno | Hydrocele testis | 7.54e-04 | 36 | 26 | 3 | HP:0000034 | |
| HumanPheno | Pilomatrixoma | 8.82e-04 | 9 | 26 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 8.82e-04 | 9 | 26 | 2 | HP:0002341 | |
| HumanPheno | Natal tooth | 8.85e-04 | 38 | 26 | 3 | HP:0000695 | |
| HumanPheno | Abnormal nasolacrimal system morphology | 8.91e-04 | 87 | 26 | 4 | HP:0000614 | |
| HumanPheno | Deviation of the hallux | 9.30e-04 | 88 | 26 | 4 | HP:0010051 | |
| HumanPheno | Capillary hemangioma | 9.55e-04 | 39 | 26 | 3 | HP:0005306 | |
| HumanPheno | Cellular immunodeficiency | 9.55e-04 | 39 | 26 | 3 | HP:0005374 | |
| HumanPheno | High, narrow palate | 9.87e-04 | 156 | 26 | 5 | HP:0002705 | |
| HumanPheno | Compulsive behaviors | 1.05e-03 | 158 | 26 | 5 | HP:0000722 | |
| HumanPheno | Frontal hirsutism | 1.10e-03 | 10 | 26 | 2 | HP:0011335 | |
| HumanPheno | Autistic behavior | CDKL5 JARID2 CHD3 ZSWIM6 PTEN CREBBP DDC EP300 PLXNA1 CAPN15 | 1.16e-03 | 678 | 26 | 10 | HP:0000729 |
| HumanPheno | Hyperactivity | 1.20e-03 | 558 | 26 | 9 | HP:0000752 | |
| HumanPheno | Mood alterations | 1.24e-03 | 164 | 26 | 5 | HP:0001296 | |
| HumanPheno | Emotional lability | 1.24e-03 | 164 | 26 | 5 | HP:0000712 | |
| HumanPheno | Abnormal sperm tail morphology | 1.27e-03 | 43 | 26 | 3 | HP:0012868 | |
| HumanPheno | Abnormal columella morphology | 1.34e-03 | 97 | 26 | 4 | HP:0009929 | |
| HumanPheno | Ventricular escape rhythm | 1.34e-03 | 11 | 26 | 2 | HP:0005155 | |
| HumanPheno | Meningioma | 1.36e-03 | 44 | 26 | 3 | HP:0002858 | |
| HumanPheno | Spina bifida | 1.49e-03 | 171 | 26 | 5 | HP:0002414 | |
| HumanPheno | Spinal cord lesion | 1.55e-03 | 46 | 26 | 3 | HP:0100561 | |
| HumanPheno | Prominent fingertip pads | 1.55e-03 | 46 | 26 | 3 | HP:0001212 | |
| HumanPheno | Severe cytomegalovirus infection | 1.60e-03 | 12 | 26 | 2 | HP:0031692 | |
| HumanPheno | Sporadic | 1.67e-03 | 103 | 26 | 4 | HP:0003745 | |
| HumanPheno | Chiari type I malformation | 1.75e-03 | 48 | 26 | 3 | HP:0007099 | |
| HumanPheno | Prominent digit pad | 1.75e-03 | 48 | 26 | 3 | HP:0011298 | |
| HumanPheno | Abnormal aortic morphology | 1.77e-03 | 363 | 26 | 7 | HP:0030963 | |
| HumanPheno | Neoplasm of the central nervous system | 1.78e-03 | 178 | 26 | 5 | HP:0100006 | |
| MousePheno | impaired coordination | 2.77e-05 | 478 | 59 | 10 | MP:0001405 | |
| MousePheno | abnormal motor coordination/balance | CDKL5 GLI2 SYNE1 PAFAH1B1 CHD6 ZSWIM6 PTEN TF CREBBP DDC MCOLN3 NOTCH3 HTT | 5.55e-05 | 873 | 59 | 13 | MP:0001516 |
| Domain | ZZ | 6.66e-07 | 18 | 74 | 4 | PF00569 | |
| Domain | ZF_ZZ_2 | 6.66e-07 | 18 | 74 | 4 | PS50135 | |
| Domain | ZF_ZZ_1 | 6.66e-07 | 18 | 74 | 4 | PS01357 | |
| Domain | Znf_ZZ | 8.41e-07 | 19 | 74 | 4 | IPR000433 | |
| Domain | ZnF_ZZ | 8.41e-07 | 19 | 74 | 4 | SM00291 | |
| Domain | Spectrin | 1.90e-06 | 23 | 74 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 5.00e-06 | 29 | 74 | 4 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 7.51e-06 | 32 | 74 | 4 | IPR018159 | |
| Domain | SPEC | 7.51e-06 | 32 | 74 | 4 | SM00150 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.55e-05 | 2 | 74 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.55e-05 | 2 | 74 | 2 | PF08214 | |
| Domain | KIX | 1.55e-05 | 2 | 74 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.55e-05 | 2 | 74 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.55e-05 | 2 | 74 | 2 | IPR031162 | |
| Domain | DUF902 | 1.55e-05 | 2 | 74 | 2 | PF06001 | |
| Domain | - | 1.55e-05 | 2 | 74 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.55e-05 | 2 | 74 | 2 | IPR010303 | |
| Domain | - | 1.55e-05 | 2 | 74 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.55e-05 | 2 | 74 | 2 | PF09030 | |
| Domain | - | 1.55e-05 | 2 | 74 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.55e-05 | 2 | 74 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.55e-05 | 2 | 74 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.55e-05 | 2 | 74 | 2 | IPR013178 | |
| Domain | KAT11 | 1.55e-05 | 2 | 74 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.55e-05 | 2 | 74 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.55e-05 | 2 | 74 | 2 | IPR003101 | |
| Domain | KIX | 1.55e-05 | 2 | 74 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.55e-05 | 2 | 74 | 2 | PS51727 | |
| Domain | KASH | 9.24e-05 | 4 | 74 | 2 | PF10541 | |
| Domain | KASH | 9.24e-05 | 4 | 74 | 2 | IPR012315 | |
| Domain | KASH | 9.24e-05 | 4 | 74 | 2 | PS51049 | |
| Domain | KASH | 9.24e-05 | 4 | 74 | 2 | SM01249 | |
| Domain | Actinin_actin-bd_CS | 9.99e-05 | 23 | 74 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 9.99e-05 | 23 | 74 | 3 | PS00020 | |
| Domain | ACTININ_1 | 9.99e-05 | 23 | 74 | 3 | PS00019 | |
| Domain | CH | 1.71e-04 | 70 | 74 | 4 | PF00307 | |
| Domain | - | 1.80e-04 | 71 | 74 | 4 | 1.10.418.10 | |
| Domain | CH | 2.01e-04 | 73 | 74 | 4 | PS50021 | |
| Domain | CH-domain | 2.23e-04 | 75 | 74 | 4 | IPR001715 | |
| Domain | Nuc_rcpt_coact | 2.30e-04 | 6 | 74 | 2 | IPR009110 | |
| Domain | EF-hand_dom_typ1 | 2.30e-04 | 6 | 74 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 2.30e-04 | 6 | 74 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 2.30e-04 | 6 | 74 | 2 | PF09068 | |
| Domain | EF-hand_3 | 2.30e-04 | 6 | 74 | 2 | PF09069 | |
| Domain | JmjN | 6.83e-04 | 10 | 74 | 2 | SM00545 | |
| Domain | JMJN | 6.83e-04 | 10 | 74 | 2 | PS51183 | |
| Domain | JmjN | 6.83e-04 | 10 | 74 | 2 | PF02375 | |
| Domain | JmjN | 6.83e-04 | 10 | 74 | 2 | IPR003349 | |
| Domain | Dynein_HC_stalk | 1.37e-03 | 14 | 74 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.37e-03 | 14 | 74 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.37e-03 | 14 | 74 | 2 | PF08393 | |
| Domain | MT | 1.37e-03 | 14 | 74 | 2 | PF12777 | |
| Domain | DHC_fam | 1.57e-03 | 15 | 74 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.57e-03 | 15 | 74 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.57e-03 | 15 | 74 | 2 | PF03028 | |
| Domain | AT_hook | 1.79e-03 | 16 | 74 | 2 | PF02178 | |
| Domain | CH | 2.19e-03 | 65 | 74 | 3 | SM00033 | |
| Domain | TIR | 3.10e-03 | 21 | 74 | 2 | SM00255 | |
| Domain | - | 3.71e-03 | 23 | 74 | 2 | 3.40.50.10140 | |
| Domain | Chromo_domain | 4.04e-03 | 24 | 74 | 2 | IPR023780 | |
| Domain | JmjC | 4.04e-03 | 24 | 74 | 2 | PF02373 | |
| Domain | TIR | 4.04e-03 | 24 | 74 | 2 | PS50104 | |
| Domain | WD40_repeat_CS | 4.09e-03 | 164 | 74 | 4 | IPR019775 | |
| Domain | TIR_dom | 4.38e-03 | 25 | 74 | 2 | IPR000157 | |
| Domain | G-protein_beta_WD-40_rep | 4.67e-03 | 85 | 74 | 3 | IPR020472 | |
| Domain | Bromodomain_CS | 4.73e-03 | 26 | 74 | 2 | IPR018359 | |
| Domain | Chromo | 4.73e-03 | 26 | 74 | 2 | PF00385 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 3.29e-05 | 17 | 53 | 3 | M48025 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 6.36e-05 | 21 | 53 | 3 | M39593 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.09e-04 | 25 | 53 | 3 | M27880 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.38e-04 | 5 | 53 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.38e-04 | 5 | 53 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.38e-04 | 5 | 53 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.38e-04 | 5 | 53 | 2 | M27228 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.06e-04 | 6 | 53 | 2 | M22062 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.88e-04 | 7 | 53 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.83e-04 | 8 | 53 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 3.83e-04 | 8 | 53 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.83e-04 | 8 | 53 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 3.83e-04 | 8 | 53 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 4.91e-04 | 9 | 53 | 2 | M47451 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 6.12e-04 | 10 | 53 | 2 | M27945 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 7.24e-04 | 47 | 53 | 3 | M7946 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 7.46e-04 | 11 | 53 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 7.46e-04 | 11 | 53 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 7.46e-04 | 11 | 53 | 2 | M26924 | |
| Pathway | WP_RETT_SYNDROME | 7.70e-04 | 48 | 53 | 3 | M39759 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 8.18e-04 | 49 | 53 | 3 | M618 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.94e-04 | 12 | 53 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 8.94e-04 | 12 | 53 | 2 | M27765 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.23e-03 | 14 | 53 | 2 | M27808 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.41e-03 | 15 | 53 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.41e-03 | 15 | 53 | 2 | MM1439 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 1.41e-03 | 15 | 53 | 2 | M48323 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M953 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.61e-03 | 16 | 53 | 2 | M27121 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.61e-03 | 16 | 53 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.61e-03 | 16 | 53 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.61e-03 | 16 | 53 | 2 | M8516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.61e-03 | 16 | 53 | 2 | M27940 | |
| Pathway | PID_P53_DOWNSTREAM_PATHWAY | 1.73e-03 | 137 | 53 | 4 | M145 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.82e-03 | 17 | 53 | 2 | MM1509 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.86e-03 | 65 | 53 | 3 | M39682 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.94e-03 | 66 | 53 | 3 | M255 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 1.94e-03 | 66 | 53 | 3 | M101 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.04e-03 | 18 | 53 | 2 | M26942 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 2.21e-03 | 69 | 53 | 3 | M48052 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 2.22e-03 | 360 | 53 | 6 | M27267 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.28e-03 | 19 | 53 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.28e-03 | 19 | 53 | 2 | M46442 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.30e-03 | 70 | 53 | 3 | M3115 | |
| Pathway | PID_AP1_PATHWAY | 2.30e-03 | 70 | 53 | 3 | M167 | |
| Pubmed | 1.00e-07 | 5 | 76 | 3 | 10698974 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TMEM144 LUC7L3 STAG3L1 GLI2 PPP1R9A CHD3 CHD6 ELK3 ZSWIM6 PTEN UTRN CREBBP EP300 NOTCH3 HTT | 6.73e-07 | 1489 | 76 | 15 | 28611215 |
| Pubmed | The centrosomal deubiquitylase USP21 regulates Gli1 transcriptional activity and stability. | 1.63e-06 | 11 | 76 | 3 | 27621083 | |
| Pubmed | 3.59e-06 | 14 | 76 | 3 | 19874786 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 4.71e-06 | 2 | 76 | 2 | 34845315 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19729597 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11792814 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 39287984 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 4.71e-06 | 2 | 76 | 2 | 24931616 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 34006834 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20717166 | ||
| Pubmed | Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. | 4.71e-06 | 2 | 76 | 2 | 16456924 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 25893291 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11559821 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 32576962 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19822209 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24522976 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 36640627 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 4.71e-06 | 2 | 76 | 2 | 21847097 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 4.71e-06 | 2 | 76 | 2 | 34813504 | |
| Pubmed | Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. | 4.71e-06 | 2 | 76 | 2 | 15994095 | |
| Pubmed | Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin. | 4.71e-06 | 2 | 76 | 2 | 16766198 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 20301699 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24639469 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 37816914 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 4.71e-06 | 2 | 76 | 2 | 11438528 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10918613 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35502657 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31898871 | ||
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 4.71e-06 | 2 | 76 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 4.71e-06 | 2 | 76 | 2 | 27881443 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19272189 | ||
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 4.71e-06 | 2 | 76 | 2 | 32690000 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30953353 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21803292 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9811832 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24089570 | ||
| Pubmed | Early alteration of epigenetic-related transcription in Huntington's disease mouse models. | 4.71e-06 | 2 | 76 | 2 | 29967375 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 4.71e-06 | 2 | 76 | 2 | 39266679 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22303793 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 4.71e-06 | 2 | 76 | 2 | 34019788 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22768332 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 15860545 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 4.71e-06 | 2 | 76 | 2 | 24551300 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 33911074 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9018065 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24648406 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30135524 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 4.71e-06 | 2 | 76 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 4.71e-06 | 2 | 76 | 2 | 29217654 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 4.71e-06 | 2 | 76 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 4.71e-06 | 2 | 76 | 2 | 29170789 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21555743 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11264541 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 4.71e-06 | 2 | 76 | 2 | 12646247 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 4.71e-06 | 2 | 76 | 2 | 17267447 | |
| Pubmed | CHD6 is a DNA-dependent ATPase and localizes at nuclear sites of mRNA synthesis. | 4.71e-06 | 2 | 76 | 2 | 17027977 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 4.71e-06 | 2 | 76 | 2 | 24718612 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24586179 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11867645 | ||
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 4.71e-06 | 2 | 76 | 2 | 11963968 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 4.71e-06 | 2 | 76 | 2 | 12696060 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 17761684 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 4.71e-06 | 2 | 76 | 2 | 36109165 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31578382 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12242694 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 31182547 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 30635043 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24491799 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 4.71e-06 | 2 | 76 | 2 | 27648933 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22116937 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 4.71e-06 | 2 | 76 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 4.71e-06 | 2 | 76 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 4.71e-06 | 2 | 76 | 2 | 15641773 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 9733868 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 4.71e-06 | 2 | 76 | 2 | 33063428 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 34506759 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 22177454 | ||
| Pubmed | 7.62e-06 | 57 | 76 | 4 | 18022353 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 18070920 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 28790157 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 30975145 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 27903646 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 12748286 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24340053 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 19273602 | ||
| Pubmed | Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. | 1.41e-05 | 3 | 76 | 2 | 11607033 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 15649887 | ||
| Pubmed | DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. | 1.41e-05 | 3 | 76 | 2 | 26951377 | |
| Pubmed | CBP/p300 and SIRT1 are involved in transcriptional regulation of S-phase specific histone genes. | 1.41e-05 | 3 | 76 | 2 | 21789216 | |
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 1.41e-05 | 3 | 76 | 2 | 12050117 | |
| Pubmed | Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. | 1.41e-05 | 3 | 76 | 2 | 16237459 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 19041714 | ||
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.45e-07 | 18 | 56 | 4 | 91 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 5.63e-05 | 4 | 56 | 2 | 1252 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 9.64e-04 | 15 | 56 | 2 | 1296 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.24e-03 | 17 | 56 | 2 | 486 | |
| Coexpression | GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP | 1.62e-06 | 198 | 75 | 7 | M4240 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.55e-05 | 230 | 74 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.32e-05 | 259 | 74 | 7 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.57e-05 | 281 | 74 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 9.90e-05 | 69 | 74 | 4 | GSM538412_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 1.11e-04 | 423 | 74 | 8 | GSM476655_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_F-2fold-vs-M_top255_255 | 1.63e-04 | 233 | 74 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_250_F-2fold-vs-M | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.11e-06 | 197 | 76 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.90e-06 | 155 | 76 | 5 | 5687416773809b8c478567bc54310af102b3029a | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-gdT|Leuk-UTI / Disease, Lineage and Cell Type | 7.57e-06 | 158 | 76 | 5 | c4b0af25608cee3d0d2b0193f5ff45d9dc87078b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.91e-06 | 167 | 76 | 5 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | Severe-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass | 1.08e-05 | 170 | 76 | 5 | 5788e1158fde036937d41708e9db3222ca351eb1 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 187 | 76 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.94e-05 | 192 | 76 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.94e-05 | 192 | 76 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.99e-05 | 193 | 76 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.99e-05 | 193 | 76 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.99e-05 | 193 | 76 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 2.04e-05 | 194 | 76 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.09e-05 | 195 | 76 | 5 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.09e-05 | 195 | 76 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 2.09e-05 | 195 | 76 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.14e-05 | 196 | 76 | 5 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 196 | 76 | 5 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 196 | 76 | 5 | c2bbb48c4aa979b03cb6f4ce9f351f492977c992 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 196 | 76 | 5 | 64c2abc0087bf2ae547932377f3662e3be1cc63e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.14e-05 | 196 | 76 | 5 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.14e-05 | 196 | 76 | 5 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.20e-05 | 197 | 76 | 5 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.20e-05 | 197 | 76 | 5 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.25e-05 | 198 | 76 | 5 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.30e-05 | 199 | 76 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.36e-05 | 200 | 76 | 5 | 61bae10c8b12196d9cee766897971b81cb897191 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 2.36e-05 | 200 | 76 | 5 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 2.36e-05 | 200 | 76 | 5 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.17e-05 | 134 | 76 | 4 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | Enterocyte-C_02|Enterocyte / shred on cell type and cluster | 8.66e-05 | 136 | 76 | 4 | daf11618c65e8fa2d77001b5c277d534cc012a4b | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 152 | 76 | 4 | d5ba87b5d34e52cef8475befafea962d70fa8a1d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 152 | 76 | 4 | d88d68a788a3256671ebbc06e104833f1f58f07d | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 152 | 76 | 4 | 3951a9f5fe164002311ed2ef7c36ae958451826b | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 154 | 76 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 154 | 76 | 4 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.47e-04 | 156 | 76 | 4 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 159 | 76 | 4 | 9f6607e395bcca9cb1c83199bdbbaaa62a93938d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-04 | 159 | 76 | 4 | c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 160 | 76 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 160 | 76 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.66e-04 | 161 | 76 | 4 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.78e-04 | 164 | 76 | 4 | b5a91f2cbfad9a2bc38aea576085a37865df955d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 165 | 76 | 4 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 165 | 76 | 4 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-04 | 166 | 76 | 4 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 167 | 76 | 4 | 10c9fab3573c2948081aac2cec1798e46e59e38a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-04 | 167 | 76 | 4 | 18e336faa2d2429ab49d1c6ae9bbf9923d74aa8d | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Lung / Manually curated celltypes from each tissue | 1.91e-04 | 167 | 76 | 4 | dcbcc658082910838c8082d71a64917055086cc4 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 168 | 76 | 4 | 4e1b522c7400c9d87f63c00e4e1dd07136095cd6 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 168 | 76 | 4 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 169 | 76 | 4 | 2de213b083f57f47be58427c0ce127fee9f85caa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 170 | 76 | 4 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.09e-04 | 171 | 76 | 4 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-04 | 68 | 76 | 3 | f1cbc6d72489272c1eb6200f64b8b6444719acda | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Cilia-bearing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.18e-04 | 173 | 76 | 4 | d4cbeae262abfa30d8c5452285d3261a96875610 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-04 | 173 | 76 | 4 | 23e50492bc673aff9df95d97f0b9be4ce57cbf01 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 174 | 76 | 4 | 919fc124affc69acfd8f575f2c372674f3d2625e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-04 | 175 | 76 | 4 | c38525583962c0e14130f4c98de912d8747bc4cb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 176 | 76 | 4 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Hippocampus|World / BrainAtlas - Mouse McCarroll V32 | 2.33e-04 | 176 | 76 | 4 | f120a703f6d2f2d5f55eae1aea2e6382a485828f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 177 | 76 | 4 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 177 | 76 | 4 | 3cfde67b93f3986312f5e74e42504214d966e7dc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 177 | 76 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | facs-Trachea-3m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 177 | 76 | 4 | 12a52a12a87a31e501ced611f46a90d172ca7e35 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 177 | 76 | 4 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 177 | 76 | 4 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 178 | 76 | 4 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 178 | 76 | 4 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 178 | 76 | 4 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 178 | 76 | 4 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-04 | 179 | 76 | 4 | d70791d2a0db35a6b013fa7ed2f9f39364581eff | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.49e-04 | 179 | 76 | 4 | 797d165718dd1d819e65add3a7859f87b32238a5 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-04 | 180 | 76 | 4 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 181 | 76 | 4 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.59e-04 | 181 | 76 | 4 | 9c4f9abb9335da2b07644bca8faff1baa1bb9f5b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-04 | 181 | 76 | 4 | 2392af8c7f040c23a7d416c2e37419954970c8f4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-04 | 182 | 76 | 4 | 0e589bf97d51b4b2f723f8c45853ad81b7ce8778 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 182 | 76 | 4 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-04 | 183 | 76 | 4 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.76e-04 | 184 | 76 | 4 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 2.76e-04 | 184 | 76 | 4 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.82e-04 | 185 | 76 | 4 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | BAL-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 2.82e-04 | 185 | 76 | 4 | e867ed55ab0df018f14bca824da09d36d83e12f9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.88e-04 | 186 | 76 | 4 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | ASK440-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.88e-04 | 186 | 76 | 4 | ce8e63057a99afa0a9cbf27ae7f9a70c0e972b6d | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.94e-04 | 187 | 76 | 4 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | COVID-NK-|COVID / Condition, Cell_class and T cell subcluster | 3.00e-04 | 188 | 76 | 4 | fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.00e-04 | 188 | 76 | 4 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.00e-04 | 188 | 76 | 4 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | COVID-NK|COVID / Condition, Cell_class and T cell subcluster | 3.00e-04 | 188 | 76 | 4 | 0beaa671611110a11e46156f54f5202cc24967a4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.06e-04 | 189 | 76 | 4 | 3e148accffc6ab249fb0dff7f3bf5a7fff9da773 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 190 | 76 | 4 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-04 | 190 | 76 | 4 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.12e-04 | 190 | 76 | 4 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 190 | 76 | 4 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 190 | 76 | 4 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-04 | 191 | 76 | 4 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-04 | 191 | 76 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 3.18e-04 | 191 | 76 | 4 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-04 | 191 | 76 | 4 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.04e-06 | 2 | 73 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 6.04e-06 | 2 | 73 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 6.04e-06 | 2 | 73 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 6.04e-06 | 2 | 73 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 6.04e-06 | 2 | 73 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.04e-06 | 2 | 73 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 6.04e-06 | 2 | 73 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 6.04e-06 | 2 | 73 | 2 | C0035934 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.61e-05 | 4 | 73 | 2 | cv:CN293514 | |
| Disease | Sezary Syndrome | 4.07e-05 | 27 | 73 | 3 | C0036920 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 6.01e-05 | 5 | 73 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 6.01e-05 | 5 | 73 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 9.00e-05 | 6 | 73 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 9.00e-05 | 6 | 73 | 2 | C0410189 | |
| Disease | Adenoid Cystic Carcinoma | 1.13e-04 | 100 | 73 | 4 | C0010606 | |
| Disease | ceroid-lipofuscinosis neuronal protein 5 measurement | 1.26e-04 | 7 | 73 | 2 | EFO_0802390 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.26e-04 | 7 | 73 | 2 | C0751337 | |
| Disease | Carcinoma, Transitional Cell | 1.45e-04 | 41 | 73 | 3 | C0007138 | |
| Disease | Huntington's disease (is_marker_for) | 3.11e-04 | 53 | 73 | 3 | DOID:12858 (is_marker_for) | |
| Disease | interleukin 1 receptor-like 1 measurement | 3.27e-04 | 11 | 73 | 2 | EFO_0008168 | |
| Disease | Macrocephaly | 3.27e-04 | 11 | 73 | 2 | C0221355 | |
| Disease | serum ST2 measurement | 3.27e-04 | 11 | 73 | 2 | EFO_0005416 | |
| Disease | Small cell carcinoma of lung | 3.29e-04 | 54 | 73 | 3 | C0149925 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.92e-04 | 12 | 73 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | biliary atresia (is_marker_for) | 5.39e-04 | 14 | 73 | 2 | DOID:13608 (is_marker_for) | |
| Disease | interleukin 18 receptor 1 measurement | 6.21e-04 | 15 | 73 | 2 | EFO_0008178 | |
| Disease | Intellectual Disability | 8.45e-04 | 447 | 73 | 6 | C3714756 | |
| Disease | glomerulonephritis (is_marker_for) | 1.00e-03 | 19 | 73 | 2 | DOID:2921 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | 1.30e-03 | 1074 | 73 | 9 | C0006142 | |
| Disease | Nasopharyngeal carcinoma | 1.35e-03 | 22 | 73 | 2 | C2931822 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.41e-03 | 195 | 73 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 1.71e-03 | 95 | 73 | 3 | C0279626 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.72e-03 | 206 | 73 | 4 | C0152013 | |
| Disease | bipolar disorder (is_implicated_in) | 2.35e-03 | 29 | 73 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 2.46e-03 | 108 | 73 | 3 | DOID:684 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CHNSSDRIKVRVWDE | 731 | Q9UPW8 | |
| EAIIWVSNKSEHHRI | 656 | Q9UKU6 | |
| NECKHHVETRWHCTV | 1671 | Q09472 | |
| WLDHSKHCLSVETEA | 81 | Q86VW2 | |
| FVLIHHCAKREDVWQ | 301 | Q86SQ6 | |
| KHHVETRWHCTVCED | 1711 | Q92793 | |
| KVQEFCREHHWITGI | 706 | Q96M86 | |
| HDAAHEIIETIRWVC | 31 | Q8TEK3 | |
| LHWACDRGHKELVTV | 196 | Q9BR61 | |
| ESAHVQRAWEHIKEL | 456 | P20711 | |
| WCSHENLHQEDLEKE | 446 | Q9BYV7 | |
| HFCDIRHLDDWAKSQ | 196 | Q7Z5Q5 | |
| DVTNRKSFEHIQDWH | 96 | Q8N4Z0 | |
| ELREHEHVVECISWA | 271 | P43034 | |
| SVDICKVHSDWQEAR | 786 | O75808 | |
| VCHALRDLVSDHVTW | 106 | Q5XUX1 | |
| DNDISIRECKDWHVS | 261 | Q8TDD5 | |
| CHECIEHIRKQNWFE | 271 | Q9H3G5 | |
| VQHVEEWHSVSCVIA | 1046 | P38570 | |
| IHDADVRHTWKSNCL | 1731 | Q9UIW2 | |
| AEEAVDCRQWTQHHL | 1741 | Q9UM47 | |
| DCRQWTQHHLVAADI | 1746 | Q9UM47 | |
| LVDHEVHESNEVWCR | 171 | Q13324 | |
| ELWKHRQDLAIVEHT | 331 | B2RXH2 | |
| DEKRSNVRWDHESVC | 21 | O95232 | |
| EHIHGEKKEFVCRWQ | 461 | P10070 | |
| VSAKDCVHVHLDLTW | 156 | Q7RTS6 | |
| IHVNLTVFEKHWCDT | 106 | Q9HB29 | |
| EAWRLHQKHVFVLSE | 246 | Q86VX9 | |
| CHSRAFQHWELIQED | 111 | P30990 | |
| QHVEEKAVHSWSRIS | 6 | Q8IV32 | |
| LFHLWHEKRCADELT | 481 | Q8N6G5 | |
| VCQNLHDSEHLTWLI | 1906 | P42858 | |
| IEETDQLWKVHCHRD | 626 | Q14241 | |
| QLWKVHCHRDFKEER | 631 | Q14241 | |
| HWSCVIIDEAHRLKN | 591 | Q8TD26 | |
| HCSWAKELQLEIFHL | 561 | Q12873 | |
| VHVETHRCNISWEIS | 141 | P14784 | |
| LDQKHEHLICWTSND | 16 | P41970 | |
| HWVADAAASVRKHLV | 281 | A6NK06 | |
| RHRWDDEVKHCFANI | 1811 | Q9NYC9 | |
| VEHLAIKCHWTQRAA | 411 | Q9NR30 | |
| KAIHWCHKNDIVHRD | 121 | O76039 | |
| ENTRHVIWKNCHKDV | 1761 | Q6ZTR5 | |
| KTTCENWREIHHLVF | 31 | Q8NE79 | |
| LWEKLTARCVDQHRH | 211 | Q13474 | |
| WLSEDDNHVAAIHCK | 111 | P60484 | |
| WRLVEEKDCHVAVHC | 851 | Q92833 | |
| ICRHSWRVVAQHLET | 196 | Q6ZUA9 | |
| HQLDEIICWLTKAEH | 2091 | P46939 | |
| DELNSHEHELCWLKD | 2026 | Q8NF91 | |
| DVCAKWESLHHELSL | 921 | Q8WXH0 | |
| WAHHEKLVIIDQSVA | 461 | Q13393 | |
| GHRCWVHILDNDTVS | 46 | Q8IVM8 | |
| GHAWLKDDEATHCRQ | 636 | Q96T51 | |
| EDVCGHWSHYQVRDK | 506 | Q6AI14 | |
| WTLHDKHREVRVKCV | 51 | P0CL83 | |
| DHRVNFHEDWKVITV | 841 | Q6P1J6 | |
| WKHISCKHAESVETE | 216 | Q9UIY3 | |
| ESKWTARVQAIHQEH | 371 | Q86YF9 | |
| CHVKHDWAFQDRDAQ | 166 | O95398 | |
| EHKDKVIQCRWHTQD | 886 | O94967 | |
| RHHKDQWFKCDDAVI | 386 | A6NNY8 | |
| LSHHERLKCDEWSVN | 366 | P02787 | |
| QDHDCKDWVHKEIVT | 631 | Q6SZW1 | |
| WVDKLSTVHHRIVGC | 176 | Q7Z5S9 | |
| LDAHEDKVWGLHCSR | 601 | Q12788 | |
| DKVWGLHCSRLDDHA | 606 | Q12788 | |
| HWEKHTCVTFIERTD | 186 | Q9Y6L7 | |
| WTLHDKHREVRVKCV | 51 | P0CL84 | |
| DHAWTCRVEHARQQL | 121 | Q14166 | |
| HQKADWDSIHEKICQ | 41 | Q9H0C1 | |
| TRAIEACDLHWQDSH | 516 | Q9HCJ5 | |
| WTLHDKHREVRVKCV | 51 | P0CL85 | |
| VHIVSEHWLLDCAQE | 966 | Q92547 | |
| HLELKHFAEAVNWCD | 161 | O95801 | |
| TLREDWECHKIRKQH | 151 | A8MT65 | |
| ADDDEHEWITRTCRK | 146 | Q5VZ52 | |
| HCNNISKIEAIDHIW | 51 | Q9C099 | |
| WIEAQTLCHTVNEHL | 736 | Q9ULJ8 |